Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Carroll

Showing results (1031-1040 of 1,078) with videos related to

Pageof 108
Sort By:
British Journal of Pharmacology|August 11, 2004
In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892Murali Gopalakrishnan, Steven A Buckner, Char-Chang Shieh, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterizationMurali Gopalakrishnan, Steven A Buckner, Kristi L Whiteaker, et al.
Obstetrics and Gynecology|June 3, 2008
Bone metabolism in pregnant women exposed to single compared with multiple courses of corticosteroidsMary A Carroll, Alex C Vidaeff, Lisa Mele, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitroWilliam A Carroll, Konstantinos A Agrios, Robert J Altenbach, et al.
BMC Geriatrics|August 17, 2022
'Value-based methodology for person-centred, integrated care supported by Information and Communication Technologies' (ValueCare) for older people in Europe: study protocol for a pre-post controlled trialE L S Bally, A van Grieken, L Ye, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain managementDerek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
Circulation. Arrhythmia and Electrophysiology|July 16, 2021
Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the <i>ADRB1</i> Arg389Arg GenotypeJonathan P Piccini, Christopher Dufton, Ian A Carroll, et al.
Neuroscience|May 5, 2007
P2X7-related modulation of pathological nociception in ratsS McGaraughty, K L Chu, M T Namovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232Eric C Larsen, Meenakshi Devidas, Si Chen, et al.
JACC. Basic to Translational Science|October 25, 2022
Myocardial Injury and Altered Gene Expression Associated With SARS-CoV-2 Infection or mRNA VaccinationNatasha L Altman, Amber A Berning, Cara E Saxon, et al.
Pageof 108

Showing results (1031-1040 of 1,078) with videos related to

Sort By:
Pageof 108
British Journal of Pharmacology|August 11, 2004
In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892Murali Gopalakrishnan, Steven A Buckner, Char-Chang Shieh, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2002
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterizationMurali Gopalakrishnan, Steven A Buckner, Kristi L Whiteaker, et al.
Obstetrics and Gynecology|June 3, 2008
Bone metabolism in pregnant women exposed to single compared with multiple courses of corticosteroidsMary A Carroll, Alex C Vidaeff, Lisa Mele, et al.
Journal of Medicinal Chemistry|May 28, 2004
Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitroWilliam A Carroll, Konstantinos A Agrios, Robert J Altenbach, et al.
BMC Geriatrics|August 17, 2022
'Value-based methodology for person-centred, integrated care supported by Information and Communication Technologies' (ValueCare) for older people in Europe: study protocol for a pre-post controlled trialE L S Bally, A van Grieken, L Ye, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2012
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain managementDerek W Nelson, Jennifer M Frost, Karin R Tietje, et al.
Circulation. Arrhythmia and Electrophysiology|July 16, 2021
Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the <i>ADRB1</i> Arg389Arg GenotypeJonathan P Piccini, Christopher Dufton, Ian A Carroll, et al.
Neuroscience|May 5, 2007
P2X7-related modulation of pathological nociception in ratsS McGaraughty, K L Chu, M T Namovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232Eric C Larsen, Meenakshi Devidas, Si Chen, et al.
JACC. Basic to Translational Science|October 25, 2022
Myocardial Injury and Altered Gene Expression Associated With SARS-CoV-2 Infection or mRNA VaccinationNatasha L Altman, Amber A Berning, Cara E Saxon, et al.
Pageof 108